» Articles » PMID: 3346073

Steric Hindrance of Antibody Binding to Surface Proteins of Coxiella Burnetti by Phase I Lipopolysaccharide

Overview
Journal Infect Immun
Date 1988 Apr 1
PMID 3346073
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The exposure of surface protein antigens on virulent phase I Coxiella burnetti was compared with that on avirulent phase II cells. Although anti-phase II antibodies did not bind to the surfaces of native intact phase I cells, they bound to phase I proteins if the proteins were solubilized for sodium dodecyl sulfate-polyacrylamide gel electrophoresis and analyzed by immunoblotting. In addition, removal of the phase I lipopolysaccharide (LPS) by trichloroacetic acid exposed surface proteins for reactivity with anti-phase II antibodies, as shown by immunofluorescence assays, direct antibody binding, and immunoelectron microscopy using protein A-colloidal gold conjugates. Based on these observations, a simple model of phase variation is proposed to explain the apparently conflicting notions of the identity of the phase II antigen(s). The model suggests that the phase I LPS sterically hinders access of anti-phase II antibodies to a multitude of shared protein antigens, any one of which may confer phase II specificity. Exposure of these shared protein antigens through the appearance of a more truncated LPS (phase II) or extraction of the smooth-type phase I LPS allows antibody accessibility and therefore confers apparent phase II serospecificity.

Citing Articles

Vaccine development: obligate intracellular bacteria new tools, old pathogens: the current state of vaccines against obligate intracellular bacteria.

Schaik E, Fratzke A, Gregory A, Dumaine J, Samuel J Front Cell Infect Microbiol. 2024; 14:1282183.

PMID: 38567021 PMC: 10985213. DOI: 10.3389/fcimb.2024.1282183.


Prevalence, Risk Factors, and Relationship between Reproductive Performance and the Presence of Antibodies against Coxiellosis in Dairy Farm Milk Tanks in the Northwest of Spain.

Yanez U, Alvarez J, Pison C, Accion A, Becerra J, Jimenez A Animals (Basel). 2024; 14(3).

PMID: 38338010 PMC: 10854522. DOI: 10.3390/ani14030367.


Natural reversion promotes LPS elongation in an attenuated Coxiella burnetii strain.

Long C, Beare P, Cockrell D, Binette P, Tesfamariam M, Richards C Nat Commun. 2024; 15(1):697.

PMID: 38267444 PMC: 10808227. DOI: 10.1038/s41467-023-43972-y.


Q Fever: A troubling disease and a challenging diagnosis.

Miller H, Priestley R, Kersh G Clin Microbiol Newsl. 2023; 43(13):109-118.

PMID: 37701818 PMC: 10493821. DOI: 10.1016/j.clinmicnews.2021.06.003.


Multivalent vaccines demonstrate immunogenicity and protect against aerosol challenge.

Jan S, Fratzke A, Felgner J, Hernandez-Davies J, Liang L, Nakajima R Front Immunol. 2023; 14:1192821.

PMID: 37533862 PMC: 10390735. DOI: 10.3389/fimmu.2023.1192821.


References
1.
Schramek S, Mayer H . Different sugar compositions of lipopolysaccharides isolated from phase I and pure phase II cells of Coxiella burnetii. Infect Immun. 1982; 38(1):53-7. PMC: 347696. DOI: 10.1128/iai.38.1.53-57.1982. View

2.
Fiset P, ORMSBEE R, Silberman R, Peacock M, Spielman S . A microagglutination technique for detection and measurement of rickettsial antibodies. Acta Virol. 1969; 13(1):60-6. View

3.
Williams J, Johnston M, Peacock M, Thomas L, Stewart S, Portis J . Monoclonal antibodies distinguish phase variants of Coxiella burnetii. Infect Immun. 1984; 43(1):421-8. PMC: 263449. DOI: 10.1128/iai.43.1.421-428.1984. View

4.
Moos A, Hackstadt T . Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model. Infect Immun. 1987; 55(5):1144-50. PMC: 260482. DOI: 10.1128/iai.55.5.1144-1150.1987. View

5.
Hackstadt T, Peacock M, Hitchcock P, Cole R . Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity. Infect Immun. 1985; 48(2):359-65. PMC: 261314. DOI: 10.1128/iai.48.2.359-365.1985. View